All Stories

  1. Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route

    Article • Drug Delivery and Translational Research, July 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  2. The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications

    Article • Current Medicinal Chemistry, July 2020, Bentham Science Publishers

    Dr. Fatima Baltazar, Sara Gomes

  3. The metabolic landscape of urological cancers: New therapeutic perspectives

    Article • Cancer Letters, May 2020, Elsevier

    Dr. Fatima Baltazar

  4. Microbes and Cancer: Friends or Faux?

    Article • International Journal of Molecular Sciences, April 2020, MDPI AG

    Dr. Fatima Baltazar

  5. IL-17A and IL-17F orchestrate macrophages to promote lung cancer

    Article • Cellular Oncology, March 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  6. Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy

    Article • Frontiers in Oncology, March 2020, Frontiers

    Dr. Fatima Baltazar

  7. A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems

    Article • Drug Delivery and Translational Research, January 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  8. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy

    Article • Nature Reviews Urology, January 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  9. Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy

    Article • Physiological Reviews, January 2020, American Physiological Society

    Dr. Fatima Baltazar

  10. Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect

    Article • January 2020, Springer Science + Business Media

    Dr. Fatima Baltazar

  11. New horizons on pH regulators as cancer biomarkers and targets for pharmacological intervention

    Article • January 2020, Elsevier

    Dr. Fatima Baltazar

  12. Fucoidan from Fucus vesiculosus inhibits new blood vessel formation and breast tumor growth in vivo

    Article • Carbohydrate Polymers, November 2019, Elsevier

    Dr. Fatima Baltazar

  13. Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy

    Article • Pharmaceutics, September 2019, MDPI AG

    Dr. Fatima Baltazar

  14. Direct actions of adiponectin on changes in reproductive, metabolic, and anti-oxidative enzymes status in the testis of adult mice

    Article • General and Comparative Endocrinology, August 2019, Elsevier

    Dr. Fatima Baltazar

  15. Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display

    Article • Scientific Reports, March 2019, Springer Science + Business Media

    Dr. Fatima Baltazar

  16. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma – MCT1 as potential target in diffuse large B cell lymphoma

    Article • Cellular Oncology, February 2019, Springer Science + Business Media

    Dr. Fatima Baltazar

  17. Role of adiponectin as a modulator of testicular function during aging in mice

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, February 2019, Elsevier

    Dr. Fatima Baltazar

  18. Synthesis, characterization and in vitro validation of a magnetic zeolite nanocomposite with T2-MRI properties towards theranostic applications

    Article • Journal of Materials Chemistry B, January 2019, Royal Society of Chemistry

    Professor Isabel C. Neves, Dr. Fatima Baltazar

  19. Photodynamic Therapy at Low-Light Fluence Rate: in vitro Assays on Colon Cancer Cells

    Article • IEEE Journal of Selected Topics in Quantum Electronics, January 2019, Institute of Electrical & Electronics Engineers (IEEE)

    Dr. Fatima Baltazar

  20. Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment

    Article • European Journal of Medicinal Chemistry, September 2018, Elsevier

    Dr. Fatima Baltazar

  21. Adenine Derivatives: Promising Candidates for Breast Cancer Treatment

    Article • European Journal of Organic Chemistry, July 2018, Wiley

    Dr. Fatima Baltazar

  22. Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy

    Article • Journal of Cellular and Molecular Medicine, May 2018, Wiley

    Dr. Fatima Baltazar

  23. The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Dr. Fatima Baltazar

  24. Internalization studies on zeolite nanoparticles using human cells

    Article • Journal of Materials Chemistry B, January 2018, Royal Society of Chemistry

    Professor Isabel C. Neves, Dr. Fatima Baltazar

  25. Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells

    Article • Oncotarget, October 2017, Impact Journals, LLC

    Dr. Fatima Baltazar

  26. Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology

    Article • Journal of Translational Medicine, October 2017, Springer Science + Business Media

    Dr. Fatima Baltazar

  27. Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy

    Article • European Journal of Pharmaceutics and Biopharmaceutics, October 2017, Elsevier

    Dr. Fatima Baltazar

  28. Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk

    Article • Molecular Carcinogenesis, August 2017, Wiley

    Dr. Rui M Reis, Professor Fatima Baltazar, Dr. Fatima Baltazar

  29. GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior

    Article • Oncotarget, July 2017, Impact Journals, LLC

    Dr. Fatima Baltazar

  30. Value of pH regulators in the diagnosis, prognosis and treatment of cancer

    Article • Seminars in Cancer Biology, April 2017, Elsevier

    Dr. Fatima Baltazar

  31. Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors

    Article • RSC Advances, January 2017, Royal Society of Chemistry

    Professor M. Fernando R Pereira, Professor Isabel C. Neves, Dr. Fatima Baltazar

  32. HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors

    Article • Theranostics, January 2017, Ivyspring International Publisher

    Dr. Fatima Baltazar

  33. Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications

    Article • Oncotarget, September 2016, Impact Journals, LLC

    Dr. Fatima Baltazar

  34. The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation

    Article • Endocrine, August 2016, Springer Science + Business Media

    Tommaso Bizzarro, Professor Fernando Schmitt, Dr. Fatima Baltazar

  35. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis

    Article • BMC Cancer, July 2016, Springer Science + Business Media

    Dr. Fatima Baltazar

  36. The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside

    Article • Journal of Bioenergetics and Biomembranes, July 2016, Springer Science + Business Media

    Dr. Fatima Baltazar

  37. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas

    Article • Oncotarget, June 2016, Impact Journals, LLC

    Dr. Fatima Baltazar

  38. Prognostic significance of monocarboxylate transporter expression in oral cavity tumors

    Article • Cell Cycle, May 2016, Taylor & Francis

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  39. Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas

    Article • Current Cancer Drug Targets, May 2016, Bentham Science Publishers

    Dr. Fatima Baltazar

  40. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4

    Article • Cell Cycle, May 2016, Taylor & Francis

    Dr. Fatima Baltazar

  41. Absence of microsatellite instability andBRAF(V600E) mutation in testicular germ cell tumors

    Article • Andrology, May 2016, Wiley

    Dr. Rui M Reis, Dr. Fatima Baltazar

  42. Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness

    Article • Cell Cycle, January 2016, Taylor & Francis

    Dr. Fatima Baltazar

  43. Colon Cancer Chemoprevention by Sage Tea Drinking: Decreased DNA Damage and Cell Proliferation

    Article • Phytotherapy Research, December 2015, Wiley

    Dr. Fatima Baltazar

  44. Targeting Metabolic Reprogramming as an Anti- Cancer Strategy: Aiming at Monocarboxylate Transporters

    Article • December 2015, Bentham Science Publishers

    Dr. Fatima Baltazar, Professor Fatima Baltazar

  45. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors

    Article • Oncotarget, November 2015, Impact Journals, LLC

    Dr. Fatima Baltazar

  46. Hotspot TERT promoter mutations are rare events in testicular germ cell tumors

    Article • Tumor Biology, November 2015, Springer Science + Business Media

    Paula Soares, Dr. Fatima Baltazar

  47. Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas

    Article • BMC Cancer, November 2015, Springer Science + Business Media

    Dr. Fatima Baltazar

  48. Glucose addiction in cancer therapy: advances and drawbacks

    Article • Current Drug Metabolism, August 2015, Bentham Science Publishers

    Professor Fatima Baltazar, Dr. Fatima Baltazar

  49. Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells

    Article • Cancer Letters, August 2015, Elsevier

    Dr. Fatima Baltazar

  50. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy

    Article • The Journal of Pathology, July 2015, Wiley

    Valdemar Máximo, Dr. Fatima Baltazar

  51. Abstract B24: Natural withanolides: A new group of anticancer drugs that selectively target the PI3K-mTOR pathway as novel potent therapeutics against colon cancers in vitro and in vivo

    Article • July 2015, American Association for Cancer Research (AACR)

    Dr. Fatima Baltazar

  52. Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria

    Article • Cell Death and Disease, June 2015, Springer Science + Business Media

    Dr. Fatima Baltazar

  53. SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3

    Article • Oncotarget, April 2015, Impact Journals, LLC

    Dr. Fatima Baltazar

  54. The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH

    Article • Biochemical Journal, April 2015, Portland Press Ltd.

    Dr. Fatima Baltazar

  55. Brain Tumor Metabolism — Unraveling Its Role in Finding New Therapeutic Targets

    Article • March 2015, IntechOpen

    Dr. Fatima Baltazar

  56. Impact of an Educational Hands-on Project on the Antimicrobial, Antitumor and Anti-Inflammatory Properties of Plants on Portuguese Students’ Awareness, Knowledge, and Competences

    Article • International Journal of Environmental Research and Public Health, February 2015, MDPI AG

    Dr. Fatima Baltazar

  57. Micro- and Mesoporous Structures as Drug Delivery Carriers for Salicylic Acid

    Article • The Journal of Physical Chemistry C, February 2015, American Chemical Society (ACS)

    Professor M. Fernando R Pereira, Professor Isabel C. Neves, Dr. Fatima Baltazar

  58. Localization of MCT 2 at peroxisomes is associated with malignant transformation in prostate cancer

    Article • Journal of Cellular and Molecular Medicine, January 2015, Wiley

    Dr. Fatima Baltazar

  59. In vitro and in vivo studies of temozolomide loading in zeolite structures as drug delivery systems for glioblastoma

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Professor Isabel C. Neves, Dr. Fatima Baltazar

  60. Urothelial bladder cancer progression: lessons learned from the bench

    Article • Journal of Cancer Metastasis and Treatment, January 2015, OAE Publishing

    Dr. Fatima Baltazar

  61. Evolving hallmarks in urothelial bladder cancer: unveiling potential biomarkers

    Article • Acta Urológica Portuguesa, January 2015, Associacao Portuguesa de Urologia

    Dr. Fatima Baltazar

  62. Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development

    Article • Evidence-based Complementary and Alternative Medicine, January 2015, Hindawi Publishing Corporation

    Dr. Fatima Baltazar, Cristina Aguiar

  63. Antitumoural and antiangiogenic activity of Portuguese propolis in in vitro and in vivo models

    Article • Journal of Functional Foods, November 2014, Elsevier

    Dr. Fatima Baltazar, Cristina Aguiar

  64. Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?

    Article • International Journal of Molecular Sciences, October 2014, MDPI AG

    Dr. Fatima Baltazar

  65. Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix

    Article • BMC Cancer, October 2014, Springer Science + Business Media

    Dr. Fatima Baltazar

  66. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype

    Article • BMC Cancer, October 2014, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  67. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance

    Article • Molecular Carcinogenesis, September 2014, Wiley

    Professor Fatima Baltazar, Dr. Fatima Baltazar

  68. T-box Transcription Factor Brachyury Is Associated with Prostate Cancer Progression and Aggressiveness

    Article • Clinical Cancer Research, July 2014, American Association for Cancer Research (AACR)

    Dr. Fatima Baltazar

  69. A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer

    Article • BMC Cancer, May 2014, Springer Science + Business Media

    Dr. Fatima Baltazar

  70. Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization

    Article • Journal of Translational Medicine, January 2014, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  71. Characterization of monocarboxylate transporter activity in hepatocellular carcinoma

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Fatima Baltazar

  72. Gene Disruption Using Zinc Finger Nuclease Technology

    Article • January 2014, Springer Science + Business Media

    Dr. Fatima Baltazar

  73. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma

    Article • Colloids and Surfaces B Biointerfaces, December 2013, Elsevier

    Professor Isabel C. Neves, Professor M. Fernando R Pereira, Dr. Fatima Baltazar

  74. Differential sensitivities to lactate transport inhibitors of breast cancer cell lines

    Article • October 2013, Bioscientifica

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  75. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma

    Article • Cell Cycle, August 2013, Taylor & Francis

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  76. Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro

    Article • BMC Complementary and Alternative Medicine, July 2013, Springer Science + Business Media

    Dr. Fatima Baltazar, Cristina Aguiar

  77. Assessing the Impact of a School Intervention to Promote Students’ Knowledge and Practices on Correct Antibiotic Use

    Article • International Journal of Environmental Research and Public Health, July 2013, MDPI AG

    Dr. Fatima Baltazar

  78. Cancer cell bioenergetics and pH regulation influence breast cancer cell resistance to paclitaxel and doxorubicin

    Article • Journal of Bioenergetics and Biomembranes, June 2013, Springer Science + Business Media

    Dr. Fatima Baltazar

  79. Contribution of Monocarboxylate Transporters to the Aggressive Phenotype of Breast Cancer

    Article • Annals of Oncology, March 2013, Elsevier

    Dr. Fatima Baltazar

  80. NIR Triggered Upconversion Nanoparticle Based Drug Delivery Systems for Photodynamic Therapy

    Article • January 2013, Optical Society of America (OSA)

    Dr. Fatima Baltazar

  81. A Hospital Based Cohort Study of Colorectal Cancer Cases Treated at Braga Hospital, Northern Portugal

    Article • Journal of Gastrointestinal & Digestive System, January 2013, OMICS Publishing Group

    Dr. Fatima Baltazar

  82. The Monocarboxylate Transporter Inhibitor α-Cyano-4-Hydroxycinnamic Acid Disrupts Rat Lung Branching

    Article • Cellular Physiology and Biochemistry, January 2013, Karger Publishers

    Dr. Fatima Baltazar

  83. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets

    Article • Neuro-Oncology, December 2012, Oxford University Press (OUP)

    Dr. Fatima Baltazar

  84. Zeolite Structures Loading with an Anticancer Compound As Drug Delivery Systems

    Article • The Journal of Physical Chemistry C, December 2012, American Chemical Society (ACS)

    Professor Isabel C. Neves, Dr. Fatima Baltazar

  85. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer

    Article • The Prostate, November 2012, Wiley

    Dr. Fatima Baltazar

  86. CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma

    Article • Diagnostic Cytopathology, May 2012, Wiley

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  87. Lactate-Induced IL-8 Pathway in Endothelial Cells--Letter

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  88. Role of monocarboxylate transporters in human cancers: state of the art

    Article • Journal of Bioenergetics and Biomembranes, February 2012, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  89. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate

    Article • Journal of Bioenergetics and Biomembranes, February 2012, Springer Science + Business Media

    Dr. Fatima Baltazar

  90. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)

    Article • Journal of Bioenergetics and Biomembranes, January 2012, Springer Science + Business Media

    Dr. Fatima Baltazar

  91. CD147 overexpression allows an accurate discrimination of bladder cancer patients’ prognosis

    Article • European Journal of Surgical Oncology, September 2011, Elsevier

    Dr. Fatima Baltazar

  92. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer

    Article • BMC Cancer, July 2011, Springer Science + Business Media

    Dr. Fatima Baltazar

  93. Encapsulation of α-cyano-4-hydroxycinnamic acid into a NaY zeolite

    Article • Journal of Materials Science, June 2011, Springer Science + Business Media

    Professor Isabel C. Neves, Dr. Fatima Baltazar

  94. Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies

    Article • World Journal of Clinical Oncology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Fatima Baltazar

  95. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma

    Article • Histopathology, June 2010, Wiley

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  96. The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment

    Article • Inflammation Research, March 2010, Springer Science + Business Media

    Dr. Fatima Baltazar

  97. Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44

    Article • Journal of Biomedicine and Biotechnology, January 2010, Hindawi Publishing Corporation

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  98. Portuguese students' knowledge of antibiotics: a cross-sectional study of secondary school and university students in Braga

    Article • BMC Public Health, September 2009, Springer Science + Business Media

    Dr. Fatima Baltazar

  99. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer

    Article • European Journal of Cancer, September 2009, Elsevier

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  100. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma

    Article • BMC Cancer, June 2009, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  101. Increasing Expression of Monocarboxylate Transporters 1 and 4 Along Progression to Invasive Cervical Carcinoma

    Article • International Journal of Gynecological Pathology, October 2008, Wolters Kluwer Health

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  102. 378 POSTER CD147 expression correlates with monocarboxylate transporters 1 and 4 in cervical carcinoma

    Article • European Journal of Cancer Supplements, October 2008, Elsevier

    Dr. Fatima Baltazar

  103. Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer

    Article • Investigational New Drugs, June 2008, Springer Science + Business Media

    Dr. Fatima Baltazar

  104. Induction of COX-2 expression by acrolein in the rat model of hemorrhagic cystitis

    Article • Experimental and Toxicologic Pathology, April 2008, Elsevier

    Dr Jose Mauricio Mota, Professor Fernando Schmitt, Dr. Fatima Baltazar

  105. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas

    Article • Virchows Archiv, January 2008, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  106. A New Model of Laryngitis: Neuropeptide, Cyclooxygenase, and Cytokine Profile

    Article • The Laryngoscope, January 2008, Wiley

    Dr. Fatima Baltazar

  107. Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers

    Article • Virchows Archiv, December 2007, Springer Science + Business Media

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  108. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix

    Article • Gynecologic Oncology, October 2007, Elsevier

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  109. Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats

    Article • Journal of Cancer Research and Clinical Oncology, July 2007, Springer Science + Business Media

    Professor Gerly Anne de Castro Brito, Professor Fernando Schmitt, Dr. Fatima Baltazar

  110. Cyclooxygenase-2 and Epidermal Growth Factor Receptor Expressions in Different Histological Subtypes of Cervical Carcinomas

    Article • International Journal of Gynecological Pathology, July 2007, Wolters Kluwer Health

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  111. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma

    Article • Diagnostic Cytopathology, January 2007, Wiley

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  112. Functional Purification of the Monocarboxylate Transporter of the Yeast Candida utilis

    Article • Biotechnology Letters, June 2006, Springer Science + Business Media

    Dr. Fatima Baltazar

  113. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

    Article • The Journal of Pathology, January 2006, Wiley

    Professor Fernando Schmitt, Dr. Fatima Baltazar

  114. Functional expression of the lactate permease Jen1p of Saccharomyces cerevisiae in Pichia pastoris

    Article • Biochemical Journal, December 2003, Portland Press Ltd.

    Dr. Fatima Baltazar

  115. l–[U–14C]Lactate binding to a 43 kDa protein in plasma membranes of Candida utilis

    Article • Microbiology, March 2000, Society for General Microbiology

    Dr. Fatima Baltazar